A Breakthrough Immunotherapy for Multiple Types of Cancer

A New Alternative for Your Patients to Fight Cancer

When it comes to cancer, time is everything. However, for many patients, potentially life-changing treatments remain within the confines of ongoing clinical trials.

Immunocine was founded to bridge this gap. Recognizing the urgent need for advanced treatment options, our sole purpose is to bring a revolutionary immunotherapy to those cancer patients unable to participate in the current clinical trials.

From our base in Cancun, Mexico, we offer our ground-breaking Dendritic Cell Immunotherapy, which is transforming outcomes for patients every day.

Physician Quick Links

A Guide to Our Treatment

Read the science behind the Immunocine Dendritic Cell Treatment (IDCT) protocol, review the treatment timeline and meet our team.

The Immunocine Difference

Read the history behind Dendritic Cells, their attempts at use in cancer treatment and how our Double-Loading makes all the difference.

Fresh Tumoral Tissue Preservation

A guide to correctly preserving biopsied or resected tissue to prevent the degradation of genetic material and molecules for immunotherapy use.

Treatment Inclusion Criteria

Review the inclusion and exclusion criteria that all patients must meet in order to receive the Immunocine Dendritic Cell Treatment.

We Treat Patients, Not Just Diseases

Immunocine was founded with the sole purpose of bringing a revolutionary immunotherapy to cancer patients unable to participate in ongoing FDA clinical trials. These are real-world, life-changing outcomes.

“As a patient, you want peace of mind and this is the best treatment in my research and experience.”

— Babette L.
Stage 4 Ovarian Cancer

Upon completion of his treatment at Immunocine, Brock witnessed an astonishing improvement in his health. He regained his mobility, and most notably, his more than 10 tumors started disappearing.

Lynn was diagnosed with terminal Stage 4 Triple Negative Breast Cancer. Despite undergoing several treatments of chemotherapy and radiation, her cancer continued to progress and had even spread to her lungs.

Our Only Priority is Treating Patients that Will Benefit from Our Treatment

Solid Tumors

While we are constantly expanding our capabilities, right now we only treat patients with solid tumors that can be biopsied by our medical staff. Blood malignancies, such as Leukemia, cannot be treated at this time.

Stable Immune System

For any immunotherapy to be successful, a patient needs to have a stable, functioning immune system. Patients with immune deficiencies and other conditions may not qualify for treatment until normal activity is restored.

Ability to Travel

Some medical conditions and other factors may prevent patients from traveling. Our treatment is administered exclusively at our facility in Cancún, Mexico. If you are unable to travel, you will not be able to receive our treatment.

Six-Week Treatment

Our treatment protocol requires three separate treatments, each two weeks apart. Patients can either choose to stay in Cancun for six weeks or visit twice for two weeks at a time.

Before considering our treatment as an option, please consider the inclusion criteria outlined. In order to be eligible, you must at least meet these requirements.

Partner With Us to Treat Your Patients

We partner with physicians regularly to provide the Immunocine Dendtritic Cell Treatment protocol to their late-stage cancer patients.

Paid Consultation

If your patient meets the minimum requirements and is interested in seeing how our treatment could work for their specific case, please submit their info on our submission form or call us directly at +1 (888) 575-2572.

Dedicated Support

Our team loves discussing our treatment with potential patients. We will schedule a call to learn about their diagnosis and answer initial questions. Prior to the call, we’ll share additional info for them to review with their physician.

Medical Evaluation

After confirming their eligibility, we will perform a complimentary medical evaluation. This includes a questionnaire and review of their medical records. Once complete, they can be approved for treatment.